Will New Trial Solution Data Spark a Rally for this Dual-Listed Gen AI Clinical Trial Leader?
29 Febrero 2024 - 9:00AM
AllPennyStocks.com
Parkinson’s disease is a complex and debilitating disease with a
need for novel treatment options. This firm’s goal is to advance
its understanding of the biological markers and...
To read the full story on AllPennyStocks.com, click
here.
NetraMark (CSE:AIAI)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
NetraMark (CSE:AIAI)
Gráfica de Acción Histórica
De May 2023 a May 2024
